Search Results

Displaying Results 9401-9425 of 27545 "'S'"

Dec 15, 2025, 08:00 ET Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

with persistent and unresolved symptoms despite first-line therapy. The product has the potential to materially accelerate our growth until the mid 2030s, and beyond. We welcome all members of the talented Arthrosi team and are looking forward to working closely together to be able to offer this therapy

More news about: Arthrosi Therapeutics


Dec 15, 2025, 08:00 ET Atossa Therapeutics Presents Four Clinical Trial Updates Highlighting (Z)-Endoxifen Research at the 2025 San Antonio Breast Cancer Symposium

unmet needKey Takeaways(Z)-Endoxifen shown to maintain potent ERα antagonist activity across key ESR1 mutations (Y537S, D538G) by stabilizing inactive receptor conformations, with computational, energetic, and metadynamics analyses showing ESR1 mutants still retain antagonist-compatible

More news about: Atossa Therapeutics Inc


Dec 15, 2025, 07:07 ET Společnost Voltage Energy získala od UL Solutions první certifikaci EBOS pro kompletní systém 2 kV v oboru

zabývající se aplikovanou bezpečnostní vědou, která poskytuje testovací, inspekční a certifikační služby s cílem pomáhat podnikům zvýšit bezpečnost, výkonnost a shodu jejich produktů a systémů s měnícími se normami a požadavky trhu, aby podporovaly bezpečnější, spolehlivější technologie a udržitelný

More news about: Voltage Energy Group


Dec 15, 2025, 07:05 ET Support for Parents with Infants at Pediatric Check-Ups Leads to Better Reading and Math Skills in Elementary School

Canfield, PhD; Ashleigh I. Aviles, PhD; and Erin Roby, PhD. University of Pittsburgh in Pennsylvania investigators are Principal Investigator Daniel S. Shaw, PhD, together with Leah J. Hunter, PhD.   Media Inquiries: Sasha Walek646-501-3873

More news about: NYU Langone Health System


Dec 15, 2025, 07:00 ET Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis

generalized pustular psoriasis: A literature review. Journal of the European Academy of Dermatology and Venereology 37, 256–273 (2022).Marrakchi, S. et al. Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis. New England Journal of Medicine 365, 620–628 (2011).Sugiura,

More news about: Vanda Pharmaceuticals Inc.


Dec 15, 2025, 07:00 ET RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells

Loscertales J, Lindblad O, Bergendahl Sandstedt A, Goede J, Baumann M, Fink AM, Fischer K, Ritgen M, Kreuzer KA, Schneider C, Tausch E, Stilgenbauer S, Robrecht S, Eichhorst B, Hallek M; CLL17 Trial Investigators. Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia. N Engl J Med. 2025

More news about: RedHill Biopharma Ltd.


Dec 15, 2025, 04:08 ET Odevo expands its U.S. footprint, entering California, Utah, and Virginia

https://news.cision.com/odevo-ab/r/odevo-expands-its-u-s--footprint--entering-california--utah--and-virginia,c4281767The following files are available for download:

More news about: Odevo AB


Dec 15, 2025, 04:00 ET Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor

candidate in immunology developed from our Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) technology. These findings underscore ASC50's potential as a best-in-class oral small molecule IL-17 inhibitor."Conference CallAscletis will host a conference call in Mandarin

More news about: Ascletis Pharma Inc.


Dec 15, 2025, 03:57 ET What's New in Helsinki 2026: Architecture, Design, Wellness and Culture

https://news.cision.com/helsinki-partners/r/what-s-new-in-helsinki-2026--architecture--design--wellness-and-culture,c4281081The following files are available for download:

More news about: Helsinki Partners


Dec 15, 2025, 03:55 ET What's New in Helsinki 2026: Architecture, Design, Wellness and Culture

https://news.cision.com/helsinki-partners/r/what-s-new-in-helsinki-2026--architecture--design--wellness-and-culture,c4281081The following files are available for download:

More news about: Helsinki Partners


Dec 15, 2025, 03:30 ET Beko reaches its seventh consecutive year with the highest S&P Global Corporate Sustainability Assessment score in the DHP Household Durables Industry

Dec. 15, 2025 /PRNewswire/ -- Beko**, a global leader in home appliances, has secured a score of 86/100 in the 2025 S&P Global Corporate Sustainability Assessment (CSA), based on the evaluation dated 16 October 2025. The company's highest standing among 79 companies

More news about: Beko


Dec 15, 2025, 03:04 ET Beko reaches its seventh consecutive year with the highest S&P Global Corporate Sustainability Assessment score in the DHP Household Durables Industry

Dec. 15, 2025 /PRNewswire/ -- Beko**, a global leader in home appliances, has secured a score of 86/100 in the 2025 S&P Global Corporate Sustainability Assessment (CSA), based on the evaluation dated 16 October 2025. The company's highest standing among 79 companies

More news about: Beko


Dec 15, 2025, 01:59 ET Update regarding Truecaller's revenue development in the fourth quarter of 2025

https://news.cision.com/truecaller-ab/r/update-regarding-truecaller-s-revenue-development-in-the-fourth-quarter-of-2025,c4281661The following files are available for download:

More news about: Truecaller AB


Dec 15, 2025, 01:28 ET Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

with persistent and unresolved symptoms despite first-line therapy. The product has the potential to materially accelerate our growth until the mid 2030s, and beyond. We welcome all members of the talented Arthrosi team and are looking forward to working closely together to be able to offer this therapy

More news about: Viva Biotech


Dec 15, 2025, 01:06 ET Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

with persistent and unresolved symptoms despite first-line therapy. The product has the potential to materially accelerate our growth until the mid 2030s, and beyond. We welcome all members of the talented Arthrosi team and are looking forward to working closely together to be able to offer this therapy

More news about: Viva Biotech


Dec 14, 2025, 21:59 ET Supermicro(スーパーマイクロ)、NVIDIA Blackwell 対応製品を拡充 4Uおよび2-OU(OCP)液冷 NVIDIA HGX B300 ソリューションを

メモリを搭載し、これまでより大規模なモデルサイズに対応することで、性能を大幅に向上させます。さらに、NVIDIA Quantum-X800 InfiniBand または NVIDIA Spectrum-4 Ethernet と組み合わせて、統合された NVIDIA ConnectX®-8 SuperNIC により、計算ファブリックのネットワークスループットを最大 800Gb/s まで倍増させ、クラスター全体の性能を向上させます。これにより、エージェンティック AI、ファウンデーションモデルの学習、マルチモーダル大規模推論など、AI ファクトリーにおける負荷の高い AI ワークロードを大幅に加速します。Supermicro は、TCO、保守性、効率性といった主要な顧客要件に応えるためにこれらのプラットフォームを開発しました。DLC-2

More news about: Super Micro Computer, Inc.


Dec 14, 2025, 17:00 ET PMET Announces Multiple New Lithium/Caesium Discoveries in 2025 Drilling at the Shaakichiuwaanaan Property

line with prior testwork, confirming a DMS-only flowsheet is applicable. The Company has also produced a marketable lithium hydroxide concentrate from CV5's spodumene concentrate. •  The Company has produced marketable tantalite concentrates at bench-scale

More news about: PMET Resources Inc.


Dec 14, 2025, 12:21 ET BTDR Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Bitdeer Technologies Group (BTDR) - Contact Kessler Topaz Meltzer & Check, LLP

Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. For more information about Kessler Topaz Meltzer

More news about: Kessler Topaz Meltzer & Check, LLP


Dec 14, 2025, 11:24 ET DXCM CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Securities Fraud Class Action Lawsuit

Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs Bar.  The firm operates globally with offices in Pennsylvania and California.  For more information about Kessler Topaz Meltzer

More news about: Kessler Topaz Meltzer & Check, LLP


Dec 13, 2025, 22:24 ET HiTHIUM stellt auf seinem dritten Eco-Day drei bahnbrechende Innovationen vor, die eine intelligente Zukunft mit Langzeit-Energiespeichern ermöglichen

Foto – https://mma.prnewswire.com/media/2844881/Jeff_Wu_s_speech.jpgLogo – 

More news about: HiTHIUM


Dec 13, 2025, 21:25 ET Gallup-McKinley County Schools clarifies state education funding process

2025. GMCS notified the New Mexico Public Education Department (NMPED), the New Mexico Attorney General, and the New Mexico State Auditor's Office of Stride/K12's alleged misconduct and the facts supporting the contract termination. Notably, NMPED received a whistleblower complaint from a Stride/K12

More news about: Gallup-McKinley County Schools


Dec 13, 2025, 21:19 ET 700CREDIT DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of 700Credit, LLC Customers Whose Data May Have Been Compromised

by the 700Credit data breach.For more information, please contact:Marc H. Edelson, Esq.EDELSON LECHTZIN LLP411 S. State Street, Suite N-300Newtown, PA 18940Phone: 844-696-7492 ext. 2Email:

More news about: Edelson Lechtzin LLP


Dec 13, 2025, 17:53 ET Award-winning journalist PJ Randhawa to deliver Northeastern Illinois University December 2025 Commencement Address

The ceremony will be held at 2 p.m. on Sunday, Dec. 14, at Credit Union 1 Arena, 525 S. Racine Ave., in Chicago. Tickets are required and made available only to graduates and their guests. The ceremony will be livestreamed at

More news about: Northeastern Illinois University


Dec 13, 2025, 16:54 ET HiTHIUM lance trois innovations décisives à l'occasion de sa troisième Eco-Day, pour un avenir intelligent grâce au stockage d'énergie de longue durée

Photo - https://mma.prnewswire.com/media/2844881/Jeff_Wu_s_speech.jpgLogo - 

More news about: HiTHIUM


Dec 13, 2025, 16:50 ET HiTHIUM lanza tres innovaciones revolucionarias en su tercer Eco-Day

Foto - https://mma.prnewswire.com/media/2844881/Jeff_Wu_s_speech.jpgLogo - 

More news about: HiTHIUM


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.